NATRILIX

This brand name is authorized in Australia, Brazil, Germany, Ecuador, Finland, Hong Kong, Ireland, Italy, Malta, Mexico, Nigeria, Singapore, United Kingdom, South Africa

Active ingredients

The drug NATRILIX contains one active pharmaceutical ingredient (API):

1 Indapamide UNII F089I0511L - INDAPAMIDE

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action. Read about Indapamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NATRILIX Prolonged-release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03BA11	Indapamide	C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2436F, 8532C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531301001113318, 531301002111319, 531301101118311, 531301102114311, 531313050005803, 531315120007303, 531315120007403
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02410239, 02520005, 02520011
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21.759-1-05-06
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 006068, 096685, 123505, 154518
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13572, 13603, 13604, 143293, 186029
Country: HK	Department of Health Drug Office	Identifier(s): 41343
Country: IE	Health Products Regulatory Authority	Identifier(s): 67363, 67370
Country: IT	Agenzia del Farmaco	Identifier(s): 024032031
Country: MT	Medicines Authority	Identifier(s): MA066/00901, PI1438/05201A, PI521/04401B, PI908/02001A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 133M2003
Country: NG	Registered Drug Product Database	Identifier(s): 04-8509
Country: SG	Health Sciences Authority	Identifier(s): 09074P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/7.1/0166